Literature DB >> 20025487

Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia.

Frank S Hong, Catherine A Mitchell, Daniela Zantomio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20025487     DOI: 10.3109/00313020903434686

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  6 in total

1.  Gelatinous transformation of bone marrow following the use of dasatinib in a patient with philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Sanjeev Kumar Sharma; Dharma Choudhary; Anil Handoo; Gaurav Kharya; Nitin Gupta; Punita Pavecha; Ritu Chadha
Journal:  Leuk Res Rep       Date:  2013-01-07

2.  Gelatinous Marrow Transformation in an Imatinib-Treated CML Patient with Pancytopenia Following Severe Sepsis.

Authors:  Pallavi Agrawal; Prashant Sharma; Vikram Narang; Neelam Varma; Pankaj Malhotra; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2012-08-23       Impact factor: 0.900

3.  Gelatinous Marrow Transformation Associated with Imatinib: Case Report and Literature Review.

Authors:  E Chang; G Rivero; B Jiang; S Yellapragada; P Thiagarajan
Journal:  Case Rep Hematol       Date:  2017-01-04

Review 4.  Gelatinous transformation of bone marrow: rare or underdiagnosed?

Authors:  Khushdeep Kaur Shergill; Gagandeep Singh Shergill; Hari Janardanan Pillai
Journal:  Autops Case Rep       Date:  2017-12-08

5.  Hyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines.

Authors:  Silvina Lompardía; Mariángeles Díaz; Matías Pibuel; Daniela Papademetrio; Daniela Poodts; Cintia Mihalez; Élida Álvarez; Silvia Hajos
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

6.  Gelatinous marrow transformation: a series of 11 cases from a tertiary care centre in South India.

Authors:  Sreeya Das; Pritinanda Mishra; Rakhee Kar; Debdatta Basu
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.